Sertoli Cell-Treated Umbilical Cord Blood for Stroke

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$133,060.00
Award Year:
2003
Program:
STTR
Phase:
Phase I
Contract:
1R41NS046878-01
Award Id:
66651
Agency Tracking Number:
NS046878
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
13101 TELECOM DR, STE 105, USF, CENTER FOR ENTREPRENEURSHIP, Tampa, FL, 33637
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
DON CAMERON
(813) 974-9431
DCAMERON@HSC.USF.EDU
Business Contact:
NICOLE KUZMIN-NICHOLS
(813) 866-6370
nkn@saneron-ccel.com
Research Institution:
UNIVERSITY OF SOUTH FLORIDA

4202 E FOWLER AVE
TAMPA, FL, 33620

Nonprofit college or university
Abstract
DESCRIPTION (provided by applicant): With the recent observations that stem-like cells outside the central nervous system (CNS) can differentiate into neurons, it is no longer inconceivable to suggest that stem cells derived from human umbilical cord blood (hUCB) could be used for cellular transplant therapy for neurological disorders, such as stroke. However, the greatest confounds of cell transplant therapy include rejection by the recipient (graft vs. host disease), and viability of the stem cells following cryopreservation. We have shown previously that SCs provide long-term localized immunosuppression and growth enhancement of transplanted cells and tissues. SCs provide a cocktail of trophic and immune protective factors that may be chronically present after transplantation. This Phase I research program proposes a series of well-controlled experiments using cell culture techniques to determine the most efficacious protocol for enhancing viability, neural differentiation, and cryopreservation of SC-treated hUCBs, which will be termed SCT-441, prior to their transplantation in an animal model of stroke. The optimal dose of SCT.441 will also be determined based on behavioral recovery. The success of directing and protecting stem cells obtained from umbilical cord blood into a neural phenotype (i.e. SCT-441) has important implications for the treatment of stroke in humans.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government